FREQUENCY AND REASONS FOR SWITCHING BACK TO ETANERCEPT ORIGINATOR FOLLOWING INITIAL SWITCH TO ETANERCEPT BIOSIMILAR

Davies, R; Kearsley-Fleet, L; Lunt, M; Watson, KD; Hyrich, KL

RHEUMATOLOGY, 2019; 58 ():